Herb-partitioned Moxibustion Plus Lifestyle Modification Treatment for Simple Obesity

Hubei Hospital of Traditional Chinese Medicine108 enrolled

Overview

This study is designed as a three-dummy randomised controlled trial to evaluate the efficacy and safety of herb-partitioned moxibustion plus lifestyle modification treatment in patients with simple obesity.

This study will be a multicenter, randomized, controlled trial conducted from November, 2018 to November, 2019 that includes 108 participants who have simple obesity and meet the eligibility criteria. The participants will be randomly divided into 3 treatment groups: heat application group, medicated plaster group, or herb-partitioned moxibustion group. Each treatment will last 4 weeks. The primary outcomes will be the clinical effectiveness.The secondary outcome measures include participants'obesity-related indicators, the IWQOL-Lite scale, and the syndrome score of Traditional Chinese Medicine. Adverse events will be recorded during the intervention period.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

108

Conditions

Obesity

Interventions

Heat application at acupointsDEVICE

1. The acupoints will be selected as Tianshu, Pishu, shenshu, zhongwan, and zusanli. The location of the acupoints were based on the national GB/T 12346-2006 acupoints standard. The hot sticker will be placed on the patient's acupoints for about 2 hours. This treatment will be applied once every other day, 3 times per week, for 4 consecutive weeks. The treatment will be delayed during the menstrual period. 2. The following lifestyle modification are recommended to help to establish healthy habits: The proportion of three nutrients in total calories comprises of 55%-65% from carbohydrates, 20%-30% from oils and 15% from protein, and the energy of the whole day distributed to three meals will follow the proportion of 30% for breakfast, 40% for lunch and 30% for dinner. Meanwhile, low-to-moderate intensity physical activities will be instructed to them for at least 5 days per week continually, 30%-50% of the maximum heart rate reserve value will be required.

Medicated plaster at acupointsDEVICE

1. The acupoints will be selected as Tianshu, Pishu, shenshu, zhongwan, and zusanli. The location of the acupoints were based on the national GB/T 12346-2006 acupoints standard.The chinese traditional medicine(aconite root, dried ginger, evodia rutaecarpa, clove, cinnamon, etc)in moderation will be grinded into powder，and the powder will be added with a certain amount of flour, and finally they will be blended with ginger juice to the appearance of mud. Next, 10g of the kneaded medicine mud will be taked and applied to the bottom of the ordinary sticker. They will be placed on the patient's acupoints for about 2 hours. The sticker has the same shape as the hot sticker, but it does not have the effect of thermal stimulation and infrared radiation. This treatment will be applied once every other day, 3 times per week, for 4 consecutive weeks. The treatment will be delayed during the menstrual period. 2. Lifestyle modification:It will be performed as the same as the heat application group.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: Participants meeting all of the following criteria will be considered for inclusion: 1. diagnosed as having simple obesity according to the diagnostic criteria; 2. aged between 18 and 45 years old; 3. Waistline: male≥ 95 cm, women≥85 cm; 4. Being able to fully understand and voluntarily sign informed consent. Exclusion Criteria: Participants will be excluded if they have 1. Presence of endocrine disorders such as: polycystic ovary syndrome; Cushing's syndrome; uncorrected thyroid disease. 2. Presence of diabetes mellitus, or hypertension, or abnormal liver and kidney functions, or mental diseases. 3. Pregnant or lactating state, women who plan to become pregnant within 4 weeks. 4. History of bulimia, anorexia, or any other eating disorders. 5. Use of medications in the past 3 months, such as diet drugs, corticosteroids, antidepressants, which may affect weight or appetite. 6. History of surgical weight loss, postoperative adhesions. 7. History of participating in a clinical study of weight loss or any other therapies to lose weight in the past 3 months. 8. Presence of local skin rupture, allergy and scar constitution. 9. Unable to cooperate with the research caused by other diseases or reasons.

Locations (1)

Zhong-Yu Zhou

Hubei, China

Outcomes

Primary Outcomes

the clinical effectiveness

The clinical effectiveness of 4 weeks of (A)Heat application group, (B)Medicated plaster group, and (C)Herb-partitioned moxibustion group for the improvement of simple obesity will be assessed and determined by the clinical evaluation of nimodipine: 1. Healing: The clinical symptoms disappear or almost disappear, and the syndrome score is reduced by ≥85 percent; 2. Significant effect: The clinical symptoms are obviously improved, and the syndrome score is reduced by \<85 percent, but ≥50 percent; 3. Effective: The clinical symptoms have improved, syndrome scores decreased by\<50 percent, but ≥30 percent; 4. Invalid: The clinical symptoms were not improved, even worse, and the syndrome score was reduced by\<30 percent. Integral variation formula(Nimodipine method: \[(pre-treatment score-post-treatment score)/pre-treatment score\]X100 percent.

Time frame: week 4.